Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Conavi Medical ( (TSE:CNVI) ) has issued an announcement.
Conavi Medical Corp. announced an upcoming investor webinar featuring CEO Tom Looby, who will discuss the company’s innovative imaging technology for cardiovascular procedures. The event, part of the Radius Research Pitch series, offers an interactive platform for investors to engage with the company, potentially enhancing Conavi’s visibility and stakeholder engagement in the medical imaging industry.
More about Conavi Medical
Conavi Medical Corp. is a company focused on designing, manufacturing, and marketing imaging technologies for minimally invasive cardiovascular procedures. Their flagship product, the Novasight Hybrid™ System, combines intravascular ultrasound and optical coherence tomography for simultaneous imaging of coronary arteries. The system has received regulatory approvals in the U.S., Canada, China, and Japan.
Average Trading Volume: 61,321
Technical Sentiment Signal: Sell
Current Market Cap: C$18.7M
See more insights into CNVI stock on TipRanks’ Stock Analysis page.